Last Updated: July 29, 2026    
     

 
 

 
 
Featured Articles

AIDS 2026 Programme

AIDS 2026 | July 26-31, 2026

Global HIV response falters as reemergence looms

AIDS 2026: UNAIDS | July 27, 2026

New collaboration between PAHO and AIDS Healthcare Foundation to expand early HIV diagnosis in Latin America and the Caribbean

AIDS 2026: PAHO | July 27, 2026

ViiV Healthcare Highlights Positive Dovato Results and Advances Long-Acting HIV Treatment Innovation at AIDS 2026

AIDS 2026: Precedence Research | July 24, 2026

   
News Updates

Scientifically, lenacapavir PrEP takes a victory lap. But now worries about access

Managed Healthcare | July 28, 2026

Activists and leaders at global HIV meeting decry price of prevention drug

Science | July 28, 2026

Amid U.S. funding cuts, the International AIDS Conference faces an uncertain future

NPR | July 28, 2026

Donor Government Funding for HIV Drops by $2.1 Billion in 2025 Due to Declines in Funding from the United States, Marking Largest Annual...

KFF | July 27, 2026

The Americas have the tools to eliminate HIV, but gaps in access and coverage remain, says PAHO

AIDS 2026: PAHO | July 27, 2026

WHO: Integration, innovation and community leadership key to ending HIV, hepatitis and STIs

AIDS 2026: WHO | July 27, 2026

High prices and funding cuts stall HIV prevention revolution

AIDS 2026: United Nations | July 27, 2026

Renee Heffron, Ph.D., M.P.H., on choice in HIV prevention

AIDS 2026: Managed Healthcare | AIDS 2026 | July 26, 2026

Gilead pressed to cut HIV prevention drug costs as global price hits $40/year

talkAfrica | July 23, 2026

AHF at AIDS 2026 Conference: AIDS Isn’t Over—and Syphilis Is Surging

AHF | July 23, 2026

Gilead, Governments Must Make HIV Prevention Medicine More Accessible

allAfrica | July 23, 2026

WCC will offer key input at International AIDS Conference in Brazil

WCC | July 23, 2026

Gilead to Present New HIV Research at AIDS 2026 Across Prevention, Treatment and Cure

GILEAD | July 21, 2026

Data revealing the impact of PEPFAR disruptions and advances in long-acting HIV prevention and treatment announced ahead of AIDS 2026

IAS | July 21, 2026

UNITAID at AIDS 2026

UNITAID | July 21, 2026

ViiV Healthcare to Present Phase Iiib Data Comparing Dovato with Biktarvy in Treatment-Naïve Adults; Alongside Insti-Powered Long-Acting...

ViiV | July 21, 2026

Merck to Present New Data on Daily, Weekly, and Monthly Options Across its HIV Treatment and Prevention Pipeline at AIDS 2026

Merck | July 15, 2026

WHO @ AIDS 2026

WHO | July 15, 2026

CHAI sessions at AIDS 2026, the 26th International AIDS Conference

Clinton Health Action Initiative | July 15, 2026

AVAC’s Guide to AIDS 2026

AVAC | July 15, 2026

AIDS 2026 webinar: highlights from Rio de Janeiro

aidsmap | July 14, 2026

AIDS 2026 news coming soon

aidsmap | July 13, 2026